These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 14679490

  • 1. Preserved diffusion capacity in children with cystic fibrosis.
    Merkus PJ, Govaere ES, Hop WH, Stam H, Tiddens HA, de Jongste JC.
    Pediatr Pulmonol; 2004 Jan; 37(1):56-60. PubMed ID: 14679490
    [Abstract] [Full Text] [Related]

  • 2. Association of body composition and lung function in children with cystic fibrosis.
    Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ.
    Pediatr Pulmonol; 2005 Mar; 39(3):276-80. PubMed ID: 15668934
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
    Li Z, Lai HJ, Kosorok MR, Laxova A, Rock MJ, Splaingard ML, Farrell PM.
    Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
    [Abstract] [Full Text] [Related]

  • 4. Nutritional growth retardation is associated with defective lung growth in cystic fibrosis: a preventable determinant of progressive pulmonary dysfunction.
    Thomson MA, Quirk P, Swanson CE, Thomas BJ, Holt TL, Francis PJ, Shepherd RW.
    Nutrition; 1995 Oct; 11(4):350-4. PubMed ID: 8580575
    [Abstract] [Full Text] [Related]

  • 5. Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis.
    Wheatley CM, Foxx-Lupo WT, Cassuto NA, Wong EC, Daines CL, Morgan WJ, Snyder EM.
    J Cyst Fibros; 2011 Jan; 10(1):45-53. PubMed ID: 21050829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Obstruction of the respiratory pathways, its evaluation by methods of functional examination of the lungs and development in patients with cystic fibrosis.
    Houstĕk J, Zapletal A, Samánek M, Vávrová V.
    Czech Med; 1979 Jan; 2(1-2):1-10. PubMed ID: 527420
    [Abstract] [Full Text] [Related]

  • 8. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM, Aebischer CC, Kraemer R, Schöni MH.
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [Abstract] [Full Text] [Related]

  • 9. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.
    Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S.
    Respir Res; 2006 Nov 30; 7(1):138. PubMed ID: 17137500
    [Abstract] [Full Text] [Related]

  • 10. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
    Cerfolio RJ, Bryant AS.
    Ann Thorac Surg; 2009 Aug 30; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
    [Abstract] [Full Text] [Related]

  • 11. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
    Aurora P, Gustafsson P, Bush A, Lindblad A, Oliver C, Wallis CE, Stocks J.
    Thorax; 2004 Dec 30; 59(12):1068-73. PubMed ID: 15563707
    [Abstract] [Full Text] [Related]

  • 12. Lung function in young adults with cystic fibrosis.
    Russell NJ, Bagg LR, Hughes DT, Neville E.
    Br J Dis Chest; 1982 Jan 30; 76(1):35-43. PubMed ID: 7059486
    [Abstract] [Full Text] [Related]

  • 13. [Pulmonary transfer factor for carbon monoxide (TLco) in healthy children and in children with chronic lung diseases, measured with an improved rebreathing technique].
    Friedrich U, Schuster J, Zimmermann T.
    Pneumologie; 1990 Oct 30; 44(10):1205-7. PubMed ID: 2281070
    [Abstract] [Full Text] [Related]

  • 14. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group.
    Arthritis Rheum; 2005 Feb 30; 52(2):592-600. PubMed ID: 15692967
    [Abstract] [Full Text] [Related]

  • 15. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
    Plastiras SC, Karadimitrakis SP, Ziakas PD, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzelepis GE.
    Arthritis Rheum; 2006 Aug 15; 55(4):598-602. PubMed ID: 16874782
    [Abstract] [Full Text] [Related]

  • 16. Comparison of carbon monoxide (CO) single breath pulmonary diffusing capacity with non-rebreathing, open-circuit CO pulmonary diffusing capacity in healthy children.
    Suman OE, Thomas S, Beck KC, Mlcak RP, Herndon DN.
    Pediatr Pulmonol; 2006 Nov 15; 41(11):1095-102. PubMed ID: 16986167
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.
    Dressel H, Filser L, Fischer R, Marten K, Müller-Lisse U, de la Motte D, Nowak D, Huber RM, Jörres RA.
    BMC Pulm Med; 2009 Jun 16; 9():30. PubMed ID: 19531222
    [Abstract] [Full Text] [Related]

  • 20. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
    Liu YX, Ye YP, Zhang P, Chen J, Ye H, He YH, Li N.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep 16; 19(9):536-8. PubMed ID: 17767822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.